Wellington Management Group
FLNA

Wellington Management Group’s Filana Therapeutics FLNA Stock Holding History

Wellington Management Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,554
Closed -$605K – 2025
2024
Q3 		$605K Buy
+20,554
New +$473K ﹤0.01% 1794
2013
Q3 		– Sell
-92,829
Closed -$1.44M – 2224
2013
Q2 		$1.44M Buy
+92,829
New +$1.96M ﹤0.01% 1694

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Wellington Management Group's FLNA Position: Q4 2024 in Review

Wellington Management Group sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 20,554 shares — an estimated $605K sold.

Wellington Management Group first reported a position in FLNA in Q2 2013 and held it in 2 quarters. The position peaked at $1.44M in Q2 2013. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Wellington Management Group reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Wellington Management Group sold 20,554 Filana Therapeutics shares in Q4 2024, an estimated $605K.
  • Wellington Management Group first reported a position in Filana Therapeutics in Q2 2013 and held it in 2 quarters.
  • Wellington Management Group's Filana Therapeutics position peaked at $1.44M in Q2 2013.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.